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The basic surface protein, BspA, has been used as a fusion partner to direct peptide antigens from the human
immunodeficiency virus gp41 protein and the Chlamydia psittaci OmpA protein to the cell surface of Lactoba-
cillus fermentum BR11. BspA has potential utility in the construction of live vaccines and diagnostic reagents.
Display of heterologous polypeptides on the surface of
gram-positive bacteria has many potential applications in the
vaccine, biotechnology, and diagnostic fields (20). Anchoring
of the heterologous polypeptide to gram-positive bacterial cell
envelope components may be either covalent or noncovalent.
Covalent attachment to the cell wall peptidoglycan is directed
by a cell wall sorting signal found in a large number of gram-
positive bacterial surface polypeptides, including Staphylococ-
cus aureus protein A and Streptococcus pyogenes M protein
(19). A variety of heterologous polypeptides have been co-
valently anchored to the gram-positive bacterial cell wall, in-
cluding antigens (5, 15), single-chain antibody fragments (4),
multisubunit polypeptides (7), and enzymes (21). Noncovalent
attachment of heterologous polypeptides to the gram-positive
bacterial cell envelope has only been investigated more re-
cently. Specific anchoring domains of noncovalently anchored
surface polypeptides, such as those from S-layer proteins (9),
muralytic enzymes (1–3), and the Listeria monocytogenes in-
ternalin B protein (3), have been used to surface display sev-
eral antigens and enzymes on gram-positive bacteria.
There is current interest in developing strains of the non-
pathogenic bacterial genus Lactobacillus as hosts for surface
expression of heterologous polypeptides (14, 26). The ability of
lactobacilli to colonize mucosal surfaces indicates that they
have potential in mucosal vaccination strategies as live recom-
binant antigen delivery vehicles (14). Thus far, surface expres-
sion systems developed for lactobacilli have been limited to
covalent anchoring of the heterologous polypeptide to the cell
wall peptidoglycan by using cell wall sorting signals of the
Lactobacillus casei proteinase PrtP (14) and the S. pyogenes M
protein (12, 13).
The guinea pig vaginal tract isolate Lactobacillus fermentum
BR11 (17) has been used previously to express and secrete
antigens (16). In this report, we investigate the potential of the
noncovalently anchored surface protein, BspA (23), as a fusion
partner for expression of heterologous antigens on the surface
of L. fermentum BR11. BspA is a member of family III of the
solute binding proteins as defined by Tam and Saier (22, 23). It
has recently been shown to be part of an L-cystine uptake
system in L. fermentum BR11 (24). BspA can be selectively
extracted from whole L. fermentum BR11 cells by a single 5 M
LiCl wash and is presumed to be electrostatically anchored to
negatively charged cell wall components (23). To test BspA as
a surface presentation vector, we have selected antigens ex-
pressed by two important pathogens (human immunodefi-
ciency virus [HIV] and Chlamydia) for which there is currently
no vaccine.
Construction of strains expressing BspA fusion proteins.
The strategy to obtain expression of bspA gene fusions from
the bspA locus of the L. fermentum BR11 chromosome is
shown in Fig. 1. We chose to fuse the heterologous antigens to
the carboxyl terminus of BspA, because it has been shown that
another family III solute binding protein member has an ex-
posed carboxyl terminus (6). The major outer membrane pro-
tein (OmpA) of Chlamydia has been extensively investigated as
a target for vaccine development. Therefore, the first antigen
tested in this system, termed OmpA(293–346), is 54 amino
acids from the Chlamydia psittaci guinea pig inclusion conjunc-
tivitis (GPIC) OmpA protein (amino acids 293 to 346), which
encompasses the variable domain 4 region (27). Regions of the
HIV Env polyprotein (e.g., the gp41 protein) have been targets
for HIV vaccine development as well as for the detection of
anti-HIV antibodies in diagnostic assays (8). The second anti-
gen used in this system, termed gp41(556–590), is 34 amino
acids from the HIV-1 Env polyprotein (amino acids 556 to
590), which includes part of the gp41 protein (10). To maxi-
mize the possibility of the heterologous sequences being ex-
posed on the fusion molecule, hydrophilic linker peptides were
inserted immediately downstream of the BspA carboxyl termi-
nus [GSGIP for BspA-OmpA(293–346) and GSGI for BspA-
gp41(556–590)]. All PCR experiments were performed with
the High Fidelity system (Boehringer Mannheim) according to
the manufacturer’s instructions. The bspA gene and part of orf3
were amplified by PCR from pMFT3 (23) by using oligonucle-
otides A (59-CGTTTCTAGAACTTGTTAGTAATGCCGG-
39) and B (59-GCGAATTCCTGAACCTTCTGTAATATCC
GCACCAA-39). The putative bspA transcription terminator
was amplified from pMFT3 with oligonucleotides C (59-AAG
GATCCTTTTGCAGTTCATTCGTTAG-39) and D (59-AAA
GGAAGCTTTGGTAATGGGGATTGCC-39) DNA encod-
ing OmpA(293–346) was amplified from a plasmid clone by
using the oligonucleotides E (59-AAGAATTCCAACATTTG
ATGCTGACTCTA-39) and F (59-CTGGATCCTTATTTGTT
GATTTGAAGCGAAG-39). DNA encoding gp41(556–590)
was amplified from a plasmid clone by using oligonucleotides
G (59-AAGAATTCGTATCCTGGCCGTCGAAC-39) and H
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The OmpA(293–346) and gp41(556–590) antigen-encoding
PCR fragments were digested with EcoRI and BamHI and
cloned into similarly digested pBluescript SK1II (Stratagene).
Ligation reactions were prepared with the following DNA mol-
ecules: EcoRI-digested bspA PCR fragment, BamHI-digested
bspA terminator PCR fragment, and either OmpA(293–346)-
or gp41(556–590)-encoding DNA fragments digested with
EcoRI and BamHI. PCRs were performed with the products of
both ligation reactions with oligonucleotides A and D. The
amplified 2.1-kb products consisted of the entire BspA fusion
protein expression cassettes. These fragments were digested
with XbaI and HindIII and cloned into similarly digested
pBluescript SK1II. DNA sequencing confirmed that no misin-
corporations had occurred in the bspA gene fusion during PCR
amplification. Both of the 2.1-kb fragments were ligated to
pJRS233 (11), and the pJRS233 derivative containing the
OmpA(293–346)-encoding DNA was named pPNG301, while
the pJRS233 derivative containing the gp41(556–590)-encod-
ing DNA was named pPNG302. pPNG301 and pPNG302 were
introduced into L. fermentum BR11 by electroporation, and
clones which contained integrated plasmids were isolated as
previously described (24) and named PNG301 and PNG302,
respectively. Escherichia coli, L. fermentum BR11, and recom-
binant strains were cultivated as described previously (24).
Analysis of expressed BspA fusion proteins. Overnight-
grown L. fermentum BR11, PNG301, or PNG302 cells (10 ml)
were extracted with 5 M LiCl as described previously (24).
Following addition of an equal volume of sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sam-
ple buffer (18), the proteins were separated by SDS-PAGE and
then either stained with Coomassie brilliant blue or electro-
blotted onto a nitrocellulose membrane (Schleicher & Schuell)
as previously described (25). The fusion proteins were detected
by standard Western blotting procedures (18) with a horserad-
ish peroxidase chemiluminescent detection kit (Boehringer
Mannheim) according to the manufacturer’s instructions.
Analysis of 5 M LiCl extracts of 13 erythromycin-resistant
pPNG301 putative integrants revealed that 6 expressed BspA-
OmpA(293–346). This fusion protein was approximately 2.5
kDa larger than BspA, as judged by SDS-PAGE analysis, and
reacted with guinea pig anti-C. psittaci GPIC serum (Fig. 2A).
Analysis of 5 M LiCl extracts of 10 erythromycin-resistant
pPNG302 putative integrants revealed that 8 expressed BspA-
gp41(556–590). There was no significant difference in the elec-
trophoretic mobility of BspA and BspA-gp41(556–590), but
the latter reacted strongly with the mouse monoclonal immu-
noglobulin M (IgM) antibody MAb-2A6, which is specific for
the gp41(556–590) antigen (Fig. 2B). Comparison of band in-
tensities in Coomassie brilliant blue-stained gels showed that
the fusions were expressed at approximately the same level as
BspA (Fig. 2A and B).
FIG. 1. Proposed mechanism for integration of the pPNG301 and pPNG302
plasmids into the L. fermentum BR11 chromosome, downstream of the bspA
promoter, via single-crossover homologous recombination. The bspA promoter is
indicated as P Ü . The DNAs encoding the gp41(556–590) and OmpA(293–346)
antigens are shown as gp41 and OmpA, respectively.
FIG. 2. Analysis of 5 M LiCl extracts from L. fermentum BR11, PNG301, and PNG302 cells. (A) On the left is Coomassie brilliant blue-stained SDS-PAGE of 5
M LiCl extracts from L. fermentum BR11 (lane 1) and PNG301 (lane 2). On the right is a Western blot of 5 M LiCl extracts from L. fermentum BR11 (lane 1) and
PNG301 (lane 2) reacted with anti-C. psittaci GPIC serum. (B) On the left is Coomassie brilliant blue-stained SDS-PAGE of 5 M LiCl extracts from L. fermentum BR11
(lane 1) and PNG302 (lane 2). On the right is a Western blot of 5 M LiCl extracts from L. fermentum BR11 (lane 1) and PNG302 (lane 2) reacted with MAb-2A6.
The numbers on the left are in kilodaltons.











The amount of BspA-gp41(556–590) extracted with 5 M
LiCl was estimated by comparing the intensity of this protein
band in Coomassie brilliant blue-stained SDS-PAGE to dilu-
tions of known amounts of lysozyme (Boehringer Mannheim).
Approximately 0.75 mg of BspA-gp41(556–590) per liter of
PNG302 stationary-phase culture could be removed selectively
by a single 5 M LiCl wash. Quantitation of the total amount of
BspA-gp41(556–590) expressed by PNG302 was estimated by
scanning Western blots and comparing the signal of the BspA-
gp41(556–590) band in the whole-cell lysate to that from the 5
M LiCl extract. Whole-cell lysates were prepared by first wash-
ing stationary-phase cells with phosphate-buffered saline
(PBS) (pH 7.4) and then resuspending them in 1 ml of 5 M
LiCl, followed by homogenization on ice for 5 3 2 min at
20,000 rpm with a Polytron homogenizer (Kinematica AG,
Lucerne, Switzerland). This extraction procedure yielded ap-
proximately 3 mg of processed BspA-gp41(556–590) per liter
of stationary-phase culture. This equates to approximately 7 3
103 BspA-gp41(556–590) molecules per cell. The proportion of
these molecules which are surface exposed, however, is un-
known. Plasmid-based expression of the S. pyogenes M6 pro-
tein on the surface of Lactococcus lactis has been reported at
levels of around 4 mg per liter of culture (culture corrected to
an optical density at 600 nm [OD600] of 1) (12). By comparison,
an equivalent culture of PNG302 cells (OD600 5 1) expresses
1.3 mg of extractable BspA-gp41(556–590) per liter.
Surface display of BspA-gp41(556–590). The accessibility of
expressed BspA-gp41(556–590) in whole cells was assessed by
using two different enzyme-linked immunosorbent assays. The
first involved the immobilization of cells on a nitrocellulose
membrane, followed by detection of the gp41(556–590) anti-
gen with Mab-2A6. Exponential-phase-grown cells (L. fermen-
tum BR11 or PNG302) were washed with PBS (pH 7) and then
resuspended to an OD600 of ’1.1 in PBS. Two microliters of
dilutions of these cell suspensions was spotted onto a nitrocel-
lulose membrane. Two microliters of 5 M LiCl extracts from L.
fermentum BR11 and PNG302 was also spotted onto the mem-
brane. The membrane then was blocked with Boehringer-
Mannheim blocking reagent and probed with MAb-2A6 at a
1:3,000 dilution for 2 h and then washed with PBS and probed
with horseradish peroxidase-conjugated anti-mouse IgM (Sig-
ma) at a 1:500 dilution. Following three more PBS wash steps,
antibody binding was detected with chloro-1-naphthol and
H2O2. To control for the amount of cells spotted onto the
membrane, an identically spotted membrane was probed with
rabbit anti-L. fermentum BR11 serum (23) at a 1:100 dilution,
washed, and then probed with horseradish peroxidase-conju-
gated anti-rabbit IgG (Dako) at a 1:1,000 dilution. The mem-
brane was then washed three times, and antibody binding was
detected by using chloro-1-naphthol and H2O2. The results
show that PNG302 cells bound MAb-2A6, whereas L. fermen-
tum BR11 cells did not (Fig. 3A). As expected, the 5 M LiCl
extract of PNG302 bound MAb-2A6 more strongly than the 5
M LiCl extract of L. fermentum BR11 (Fig. 3A). There was no
visible difference in the ability of these strains to bind anti-L.
fermentum BR11 antibodies (Fig. 3A).
The second surface accessibility protocol is based on a pro-
cedure previously reported (7) and was designed to ensure that
any binding observed was not due to fusion protein released
from lysed cells. First, exponential-phase-grown cells (L. fer-
mentum BR11 or PNG302) were washed with PBS and then
resuspended to an OD600 of ’1.1 in PBS-Tween (0.05%
Tween 20). Three aliquots (900 ml each) of each strain were
then incubated for 30 min with 100 ml of MAb-2A6 diluted
1:300. Following two washes with PBS-Tween, the cells were
incubated for 15 min with 1 ml of horseradish peroxidase-
conjugated antimouse IgM diluted 1:1,000. After being washed
twice in PBS-Tween, the cells were resuspended in 1.5 ml of
FIG. 3. Colorimetric assays for the detection of cell surface-displayed gp41(556–590). (A) Dilutions of L. fermentum BR11 (BR11) and PNG302 cell suspensions
were spotted onto duplicate nitrocellulose membranes (from left to right: undiluted, 1:2 diluted, and 1:4 diluted). Also, 5 M LiCl extracts from L. fermentum BR11 and
PNG302 were spotted onto the bottom right of the membranes. The membranes were either reacted with MAb-2A6 or with anti-L. fermentum BR11 serum. (B) L.
fermentum BR11 (BR11) and PNG302 cells were incubated with MAb-2A6, allowing it to bind to surface-displayed gp41(556–590) antigen. This binding was quantified
by using a horseradish peroxidase-conjugated secondary antibody and a chromogenic substrate. The results are displayed as the means of the A450 per OD600 unit of
the cells, and the standard deviations are shown by error bars.











Tris-buffered saline. Four aliquots (50 ml each) of each of the
cell suspensions were loaded into wells of a microtiter plate,
and 50 ml of 3,39,5,59-tetramethylbenzidine (ELISA Systems,
Graphic Scientific Pty. Ltd., Brisbane, Australia) was added.
Following color development, the reaction was stopped by the
addition of 50 ml of 3 M HCl, and the increase in A450 was
measured by an automated plate reader. A total of 12 absor-
bance readings of each of the strains were taken into account
when calculating the means and standard deviations. Although
some background MAb-2A6 binding to L. fermentum BR11
cells was observed with this assay, a significant increase in
binding was observed for PNG302 cells (Fig. 3B), thus con-
firming that BspA-gp41(556–590) is exposed on the surface of
PNG302. Due to the strong cross-reactivity of the anti-C.
psittaci GPIC serum with L. fermentum BR11 proteins, surface
display of BspA-OmpA(293–346) was not tested. The reason
for the significant binding of unmodified L. fermentum BR11 to
Mab-2A6 in the centrifugation-based assay, but not in the
membrane-based assay, is unknown, but it may be because a
blocking procedure was carried out immediately prior to the
application of the antibody in the membrane-based assay, but
not in the centrifugation-based assay.
BspA is involved in L-cystine uptake and therefore must be
able to directly contact the cytoplasmic membrane in order to
interact with the membrane-located translocation complex
(24). Since BspA-gp41(556–590) in whole L. fermentum cells
can bind MAb-2A6, it is likely that at least some BspA is also
located near the external side of the cell wall peptidoglycan of
L. fermentum BR11. Alternatively, MAb-2A6 may be able to
penetrate the cell wall peptidoglycan; however since this anti-
body is of the IgM class and is therefore a large pentameric
molecule, this seems unlikely. Due to the proposed nonspecific
nature of anchoring of BspA to the surface of L. fermentum
BR11 cells, BspA may be able to be used to anchor heterolo-
gous polypeptides to the surface of other Lactobacillus strains.
The BspA surface expression system developed in this study
has potential for the development of live vaccine candidates or
diagnostic reagents. Other biotechnological applications for
this system include the immobilization of enzymatic molecules
or single-chain antibodies on gram-positive bacterial cell sur-
faces. The fast and simple 5 M LiCl extraction procedure for
purifying BspA fusion proteins from whole cells indicates that
this system may also be useful simply for the expression and
purification of recombinant proteins. We are currently inves-
tigating several of these applications.
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